Bristol-Myers Squibb Co. (BMY)
The Company, through its divisions and subsidiaries, is engaged in the discovery, development, licensing, manufacturing, marketing, distribution and sale of pharmaceuticals and other health care related products.
Recs
Strong dividend, strong earnings. This one adds some safety to my real life aggressive portfolio
Recs
Fat yield.
Recs
BMY is a solid company with a great dividend. People will be looking for such a stable company to balance their portfolios. I don't think Obama's health care plan will hurt it either.
Recs
Lilly is about to lose its protection (patents expiring). There will be rationalization in the industry as players take advantage of new generic-drug alternatives. BMY has saved the cash needed to make some good acquisitions, which will accelerate its performance.
Recs
good time to buy - good dividend @ 5.5% - real potential for takeover in near furure-eh
Recs
safe high yield
Recs
positive independent ratings. best drug manufacturer. S&P 5 stars. 5.5% div. historically low PE of 13 x's trailing EPS.
Recs
Abilify for adjunctive treatment of depression has been a huge success and patients are reporting results within 1-2 weeks which is unprecedented for an antidepressant (unless it's placebo effect). Analysts are aware of the potential here, but I think the next set of earnings will beat.
Recs
Momentum / defensive pick
Recs
P/E is not overly high. There's a good dividend and they have enough cash on hand to completely cover their LT debt.
Recs
Leading Pharma
Recs
Quality Med Related company, Bargain price, Great Dividend history. I like my chances.
Recs
Passws the Geraldine Weiss criteria as of Sep 6, 2009
Recs
High dividend yield, Underpriced. Low risk and steady growth
Recs
Drug company that produces everyday items. Enough said.
Recs
well below average price, this company has at least 2 years to go on its shining light, Plavix, though this drug has seen some headwind recently, not enough to affect sales.Pipeline good, sales excellent.keeping it simple too, by not over-subscribing to takeover temptations
Recs
Another addition to my pharma collection
Recs
Best drugs I ever had
Recs
Bristol Myers has just purchased a company, one that is costly not creating cash flow yet. Set back = Time Medex does have diamonds awaiting them with BMY's good management.
Recs
Ford Strong Buy, S&P (4 or 3 stars), Member of S&P 500

RSS Headlines
Fool UK
- Show Me:
-
Outperform
-
Underperform
-
All
- Sort by:
-
Author
-
Recs
-
Date
-
Member Rating
-
Results 1 - 20 of 218 1 2 3 4 5 6 7 8 9 10 Next »